jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Aldolase enzymatic

Blood
image

Report in 120Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Enzyme involved in glycolysis; elevated in muscle damage.

1,1621,660

30% OFF

Aldolase Enzymatic Test - Comprehensive Medical Guide

  • Why is it done?
    • Test measures the enzyme aldolase (also called fructose-1,6-bisphosphate aldolase), which is released into the bloodstream when muscle or liver cells are damaged or broken down
    • Ordered to diagnose or monitor muscle diseases (myopathies) including muscular dystrophy, dermatomyositis, and polymyositis
    • Used to evaluate liver damage or disease, including hepatitis, cirrhosis, and liver necrosis
    • Performed when patients present with muscle weakness, pain, or elevated creatine kinase (CK) levels
    • May be ordered following acute myocardial infarction (heart attack) or severe muscle trauma
    • Used to monitor treatment efficacy in inflammatory muscle conditions and to assess disease progression
  • Normal Range
    • Normal aldolase levels: 1.0 to 7.5 U/L (units per liter) in most laboratories
    • Normal values may vary slightly between laboratories based on their reference ranges and methodology used
    • Results are typically reported in U/L (units per liter) or sometimes as IU/L (international units per liter)
    • Normal/Negative: Aldolase within the laboratory's established reference range indicates no evidence of significant muscle or liver cell damage
    • Elevated/Abnormal: Levels above 7.5 U/L suggest muscle or liver tissue breakdown; the degree of elevation correlates with the severity of tissue damage
    • Slightly elevated: 7.5-15 U/L (mild elevation, may warrant further investigation)
    • Moderately to markedly elevated: >15 U/L (significant elevation suggesting substantial tissue damage or active disease process)
  • Interpretation
    • Mild Elevation (1.5 to 3 times normal): May indicate early-stage muscle disease, mild liver injury, hemolysis, or recent minor muscle trauma
    • Moderate Elevation (3 to 10 times normal): Suggests active myositis, muscular dystrophy, acute hepatitis, or significant muscle injury
    • Marked Elevation (>10 times normal): Indicates severe muscle disease, rhabdomyolysis, acute severe hepatitis, or extensive tissue damage
    • Progressive Elevation Over Time: May indicate worsening disease or inadequate treatment response
    • Declining Elevation Over Time: May indicate disease stabilization, treatment response, or recovery from acute injury
    • Factors Affecting Results:
    • Recent strenuous exercise or muscle trauma can elevate aldolase levels
    • Hemolysis (red blood cell breakdown) during blood draw can cause falsely elevated results
    • Pregnancy and certain medications may affect aldolase levels
    • Age, sex, and body composition may influence baseline aldolase levels
    • Timing of sample collection relative to acute muscle injury affects interpretation
  • Associated Organs
    • Primary Organ Systems:
    • Skeletal muscle system - primary source of aldolase elevation in muscle diseases
    • Hepatic (liver) system - significant aldolase source in liver disease
    • Muscle Diseases Associated with Elevated Aldolase:
    • Muscular dystrophies (Duchenne, Becker, limb-girdle, and facioscapulohumeral types)
    • Inflammatory myopathies: dermatomyositis, polymyositis, and inclusion body myositis
    • Rhabdomyolysis - massive muscle breakdown causing severe elevation
    • Glycogen storage diseases (especially types II, III, IV, and V)
    • Mitochondrial myopathies
    • Liver Conditions Associated with Elevated Aldolase:
    • Acute hepatitis (viral, autoimmune, or drug-induced)
    • Cirrhosis and chronic liver disease
    • Hepatocellular carcinoma and other liver tumors
    • Liver necrosis and fulminant hepatic failure
    • Other Conditions:
    • Acute myocardial infarction (heart attack) - cardiac muscle damage
    • Severe hemolysis causing release of red blood cell aldolase
    • Sepsis and severe systemic infections affecting multiple organ systems
    • Associated Complications and Risks:
    • Muscle disease progression may lead to weakness, mobility loss, and respiratory compromise
    • Severe muscle injury can cause myoglobinuria leading to acute kidney injury
    • Uncontrolled liver disease progression may result in hepatic failure and cirrhotic complications
  • Follow-up Tests
    • For Suspected Muscle Disease:
    • Creatine kinase (CK) and CK-MB - more specific muscle damage markers
    • Lactate dehydrogenase (LDH) - another tissue damage enzyme marker
    • Myoglobin - indicates severe muscle breakdown, especially rhabdomyolysis
    • Electromyography (EMG) - assesses muscle electrical activity and function
    • Muscle biopsy - confirms diagnosis of myositis or muscular dystrophy
    • Genetic testing - if hereditary muscle disease is suspected
    • Autoantibody panels - for dermatomyositis, polymyositis (anti-Jo-1, anti-Mi-2, etc.)
    • For Suspected Liver Disease:
    • Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) - liver enzymes
    • Alkaline phosphatase and gamma-glutamyl transferase (GGT) - cholestasis markers
    • Total and direct bilirubin - assess liver function and cholestasis
    • Albumin and prothrombin time (PT/INR) - assess synthetic liver function
    • Viral hepatitis serology (Hepatitis A, B, C antibodies and antigens)
    • Hepatic ultrasound or CT imaging - visualize liver structure and pathology
    • Liver biopsy - when imaging results are inconclusive or cirrhosis is suspected
    • For Rhabdomyolysis or Severe Muscle Injury:
    • Serum creatinine and blood urea nitrogen (BUN) - assess kidney function
    • Urinalysis with myoglobin - detect myoglobinuria and kidney involvement
    • Electrolytes (sodium, potassium, calcium, phosphate) - monitor for dangerous imbalances
    • Monitoring Frequency:
    • Acute conditions: May repeat aldolase every 24-48 hours to monitor progression or recovery
    • Chronic muscle disease: Typically monitored monthly to quarterly depending on treatment response
    • Liver disease: Monitoring intervals vary from weekly in acute cases to annually in stable chronic disease
  • Fasting Required?
    • Fasting: No - fasting is NOT required for aldolase testing
    • Blood can be drawn at any time of day regardless of meal intake
    • Patient Preparation Instructions:
    • Avoid strenuous exercise or heavy exertion for 24 hours prior to testing if possible, as this can elevate aldolase levels
    • Inform the healthcare provider of any recent muscle injuries or trauma
    • Wear comfortable clothing that allows easy access to the arm for blood draw
    • Medications:
    • Continue taking all regularly prescribed medications unless specifically instructed otherwise by the physician
    • Inform the healthcare provider of any medications, supplements, or herbal products being taken, as some may affect results
    • Corticosteroids, statins, and certain anticonvulsants may influence aldolase levels
    • Timing Considerations:
    • For acute conditions, blood should be drawn as soon as possible after symptom onset when aldolase levels are highest
    • For chronic monitoring, consistent sampling time (morning) may improve result comparability
    • Special Circumstances:
    • If multiple laboratory tests are being performed at the same time, only one blood draw is typically needed
    • Report any excessive bleeding or bruising at the puncture site to healthcare personnel
    • Sample should be processed promptly to prevent hemolysis which can falsely elevate results

How our test process works!

customers
customers